← Research LibraryThe BriefFY2026 20-F · headline figures audited against SEC data
Infosys grew revenue 4.6% to $20.16B and net income 4.9% to $3.31B, but lower utilization and India's new Labour Codes cut operating margin 86 bps while it returned cash through a $2,006 million buyback and $2.13B of dividends
The read at a glance✓ Audited against SEC data
- Growth — Revenue up 4.6% to $20.16B; 3.1% in constant currencyNote
- Profitability — Operating margin down 86 bps to 20.26%Watch
- Balance sheet — No outstanding borrowingsOK
- Accounting quality — Distress-safe balance-sheet screen; clean auditOK
- Capital allocation — Buyback $2,006 million; dividends $2.13BOK
- Client concentration — Top five clients 12.9% of revenueNote
Business
Infosys, founded in 1981 and headquartered in Bengaluru, sells IT consulting, application development and management, cloud, engineering and business process services to large companies, delivered mostly from India by 328,594 employees. North America provided 56.1% of fiscal 2026 revenue and Europe 32.1%. Its pitch now is AI services built on its Topaz platforms, alongside software products such as Finacle banking software.
Latest filings
- 6-K · Company announcement (foreign filer)2026-10-28
- 6-K · Company announcement (foreign filer)2026-10-23
- 6-K · Company announcement (foreign filer)2026-10-13
- 6-K · Company announcement (foreign filer)2026-07-28
- 6-K · Company announcement (foreign filer)2026-07-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Infosys Ltd, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.